2 completed, 2 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Batoclimab: new trials by email Literature Review of Batoclimab trials Research Report on Batoclimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Batoclimab - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Terminated | Immunovant Sciences GmbH | 26 | 2025-08-28 | 2026-08-11 |
| Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease Batoclimab, Placebo - Thyroid Eye Disease | Phase 3 | Completed | Immunovant Sciences GmbH | 86 | 2023-01-05 | 2026-04-01 |
| Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease Batoclimab, Placebo - Thyroid Eye Disease | Phase 3 | Completed | Immunovant Sciences GmbH | 114 | 2022-11-23 | 2025-12-03 |
| Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease Observational cohort study, Batoclimab - Thyroid Eye Disease | Phase 3 | Terminated | Immunovant Sciences GmbH | 109 | 2022-11-06 | 2026-04-29 |
Autoimmune Diseases (4) · Graves Ophthalmopathy (3) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
United States (4) · Belgium (3) · Germany (3) · Italy (3) · Poland (3) · Slovakia (3) · Australia (2) · Georgia (2) · Hungary (2) · Israel (2) · Latvia (2) · New Zealand (2) · Puerto Rico (2) · Spain (2) · United Kingdom (2)